id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2011-N-0231-0011,FDA,FDA-2011-N-0231,Agency Information Collection Activities: Proposed Collection; Comment Request; Adverse Experience Reporting for Licensed Biological Products; and General  Records,Notice,60 Day Proposed Information Collection,2020-09-01T04:00:00Z,2020,9,2020-09-01T04:00:00Z,2020-11-03T04:59:59Z,2023-09-07T21:08:45Z,2020-19239,0,0,090000648482d8bb